Susquehanna International Group
ACHV icon

Susquehanna International Group’s Achieve Life Sciences ACHV Stock Holding History

Susquehanna International Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Sell
383,683
-112,667
-23% -$500K ﹤0.01% 7566
2025
Q4 		$2.47M Buy
496,350
+129,987
+35% +$567K ﹤0.01% 5218
2025
Q3 		$1.15M Buy
366,363
+293,648
+404% +$806K ﹤0.01% 7011
2025
Q2 		$164K Sell
72,715
-7,960
-10% -$22.7K ﹤0.01% 11408
2025
Q1 		$215K Buy
80,675
+58,141
+258% +$181K ﹤0.01% 10794
2024
Q4 		$79.3K Buy
+22,534
New +$102K ﹤0.01% 11471
2024
Q2 		– Sell
-44,653
Closed -$215K – 11919
2024
Q1 		$203K Buy
+44,653
New +$198K ﹤0.01% 10570
2023
Q4 		– Sell
-11,290
Closed -$49.2K – 12249
2023
Q3 		$48.5K Buy
+11,290
New +$56.9K ﹤0.01% 11322
2023
Q1 		– Sell
-20,755
Closed -$98.6K – 12455
2022
Q4 		$51.3K Sell
20,755
-8,522
-29% -$21.9K ﹤0.01% 11388
2022
Q3 		$97K Sell
29,277
-13,022
-31% -$62.1K ﹤0.01% 11730
2022
Q2 		$206K Sell
42,299
-38,145
-47% -$259K ﹤0.01% 10553
2022
Q1 		$609K Sell
80,444
-19,858
-20% -$148K ﹤0.01% 8446
2021
Q4 		$780K Buy
100,302
+74,965
+296% +$589K ﹤0.01% 7945
2021
Q3 		$215K Buy
+25,337
New +$199K ﹤0.01% 11327
2021
Q1 		– Sell
-10,510
Closed -$85K – 12171
2020
Q4 		$85K Buy
+10,510
New +$89K ﹤0.01% 10573
2020
Q2 		– Sell
-1,054
Closed -$7K – 10029
2020
Q1 		$7K Buy
+1,054
New +$10.2K ﹤0.01% 10068
2018
Q4 		– Sell
-1,482
Closed -$93K – 8829
2018
Q3 		$93K Buy
+1,482
New +$93.7K ﹤0.01% 8630
2018
Q2 		– Sell
-133
Closed -$34K – 9507
2018
Q1 		$34K Buy
133
+76
+133% +$21.7K ﹤0.01% 9053
2017
Q4 		$15K Buy
+57
New +$18.2K ﹤0.01% 9095
2017
Q3 		– Sell
-35
Closed -$28K – 8727
2017
Q2 		$28K Buy
+35
New +$28.4K ﹤0.01% 8982
2017
Q1 		– Sell
-38
Closed -$42K – 8818
2016
Q4 		$42K Buy
38
+7
+23% +$6.92K ﹤0.01% 9327
2016
Q3 		$35K Buy
+31
New +$49.4K ﹤0.01% 8196
2016
Q1 		– Sell
-10
Closed -$25K – 8925
2015
Q4 		$25K Sell
10
-15
-60% -$63.4K ﹤0.01% 9198
2015
Q3 		$123K Buy
25
+19
+317% +$114K ﹤0.01% 9032
2015
Q2 		$32K Buy
+6
New +$29.8K ﹤0.01% 9939
2015
Q1 		– Sell
-20
Closed -$98.2K – 9341
2014
Q4 		$99K Sell
20
-14
-41% -$68.4K ﹤0.01% 9191
2014
Q3 		$198K Sell
34
-41
-55% -$285K ﹤0.01% 8691
2014
Q2 		$618K Buy
75
+32
+74% +$393K ﹤0.01% 7069
2014
Q1 		$1.12M Buy
43
+37
+617% +$909K ﹤0.01% 5314
2013
Q4 		$114K Buy
+6
New +$105K ﹤0.01% 8579

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's ACHV Position: Q1 2026 in Review

Susquehanna International Group reduced its Achieve Life Sciences (ACHV) stake by 23% in Q1 2026, selling an estimated $500K and leaving 383,683 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #7566.

Susquehanna International Group first reported a position in ACHV in Q4 2013 and has held it in 30 quarters since. The position peaked at $2.47M in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Susquehanna International Group held 383,683 shares of Achieve Life Sciences worth $1.13M as of Q1 2026.
  • Susquehanna International Group sold 112,667 Achieve Life Sciences shares in Q1 2026, an estimated $500K.
  • Achieve Life Sciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7566 holding.
  • Susquehanna International Group first reported a position in Achieve Life Sciences in Q4 2013 and has held it in 30 quarters since.
  • Susquehanna International Group's Achieve Life Sciences position peaked at $2.47M in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.